Wrap Proxy Amendment Adds Delatorre Nominee; Seeks 300M Authorized Shares and Series C Conversion Approval
WRAP is trading near its 52-week low of $1.04 (12% above the low) on elevated volume (1.8× avg).
Summary
Wrap's amended annual-meeting proxy asks holders to lift authorized shares to 300 million and clear Nasdaq's 20% cap for a full-ratchet Series C preferred conversion at $1.40, and adds new director nominee Edward Delatorre.
Key Events · Corporate Governance and Compliance · WRAP
-
Authorized Shares Would Rise to 300 Million
Proposal 4 amends the charter to increase authorized common stock from 200,000,000 to 300,000,000 shares, with total authorized capital going from 205,000,000 to 305,000,000; no shares are issued by the vote itself.
-
Series C Conversion Clears Nasdaq 20% Cap
Proposal 5 authorizes issuing Series C underlying shares above 12,399,477 shares (20% of the 61,997,384 outstanding on October 15, 2026); the initial 5,790,714 conversion shares at the $1.40 conversion price equal about 9.34% of the pre-issuance count.
-
Full-Ratchet and 8% Stock Dividends Add Dilution
The Series C conversion price resets downward on any below-price issuance, and dividends accrue at 8% per annum payable in stock at the lower of the conversion price or 85% of the three lowest closing prices in the prior 20 trading days, so the ultimate share count cannot be determined.
-
Failure to Approve Forces Cash Dividends
Without approval the company cannot pay Series C dividends or conversions in stock and would have to satisfy them in cash, or delay, reduce or eliminate programs, sell assets, or merge.
Analysis · WRAP · Manufacturing
Two proposals at the December 11, 2026 annual meeting could sharply expand the share count. Proposal 4 would raise authorized common stock from 200,000,000 to 300,000,000 shares — permission only, no shares issued yet — against 61,997,384 shares outstanding on the October 15, 2026 record date. Proposal 5 clears Nasdaq's 20% cap so the Series A preferred can be exchanged into Series C preferred convertible at $1.40 with a full-ratchet anti-dilution reset and 8% dividends payable in stock at 85% of market; the company says the initial 5,790,714 conversion shares equal roughly 9.34% of the pre-issuance count, but the ratchet and dividend shares make the ultimate total unknowable. If holders vote no, the company warns it would have to pay dividends in cash or sell assets. The amendment itself adds Edward Delatorre, appointed October 20, 2026, as a seventh nominee and restates the Series C certificate of designations.
How filings like this one have moved
In the 30 days to Oct 26, 2026, 36.2% of the 898 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.75%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, WRAP was trading at $1.16 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $71.3M. The 52-week trading range was $1.04 to $3.23. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.